Rhythm Pharmaceuticals, Inc. - RYTM Total Company Value-to-Revenue Ratio

rhythmtx.com (RYTM) - corporate logo

Rhythm Pharmaceuticals generates revenue from the sale of its unique drug IMCIVREE, leveraging high trust among physicians and patients. The EV-to-annual revenue multiple confirms the market value of the assets, with the parameter stabilizing at 28483.24. Management, led by David Meeker, demonstrates deep scientific expertise and the ability to interact effectively with regulators.

RYTM Rhythm Pharmaceuticals: Enterprise Value-to-Revenue Ratio in the range 11/23/2025 - 11/20/2026

Rhythm Pharmaceuticals Inc - analytical breakdowns and key metrics (RYTM)

Product sample of Rhythm Pharma

Expensive specialized cold-chain aviation logistics for Rhythm Pharmaceuticals (RYTM) drugs require significant capital expenditures, which directly impact operational efficiency. By analyzing the Enterprise Value to revenue ratio, an investor views the business value excluding debt load, allowing them to filter out market noise and determine the real valuation dynamics of the asset relative to its cash flow generation.

Direct competitors

ASND: Enterprise Value-to-Revenue Ratio|MDGL: EV/Sales Multiple|CORT - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Akero Corp|Metsera Therapeutics (MTSR) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio moonlaketx.com (MLTX)|Company Value to Revenue Crinetics Pharmaceuticals CRNX|Enterprise Value-to-Revenue Ratio NewAmsterdam Pharma N.V. NAMS|Total Company Value-to-Revenue Ratio Soleno Therapeutics Inc (SLNO)|FOLD - Enterprise Value-to-Revenue Ratio|ETNB: Enterprise Value-to-Revenue Ratio|AGIO: EV/Sales Multiple|Structure Therapeutics Inc. - Business Value to Revenue|MDXG (MiMedx Corp) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple Rezolute Inc RZLT|EV/Sales Multiple LXRX|Total Company Value-to-Revenue Ratio MBX Corp|Altimmune Pharma - Company Value to Revenue|EV/Sales Multiple aardvarktherapeutics.com AARD|SGMT: Company Value to Revenue|Business Value to Revenue BIOA (BioAge Labs)|BMEA: EV/Sales Multiple|QNCX: Enterprise Value-to-Revenue Coefficient|GUTS (Fractyl Health, Inc.) - EV/Sales Multiple|EV/Sales Multiple vtvtherapeutics.com|Company Value to Revenue ATPC (Agape ATP Corp)|Total Company Value-to-Revenue Ratio Pluristem Therapeutics|Enterprise Value-to-Revenue Ratio synlogictx.com SYBX|LPCN: Company Value to Revenue Ratio|MTNB - Enterprise Value-to-Revenue Ratio|Spruce Biosciences, Inc. (SPRB) - Company Value to Revenue|GLTO: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - EV/Sales Multiple|Organovo Corp (ONVO) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Radius Recycling (RDUS)